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source, representing the health care experience of enrollees in
employer-sponsored health plans in the U.S. The study popula-
tion consisted of 22,985 children 5 to 17 years old and 56,381
adults 18 to 54 years old, meeting the HEDIS criteria for per-
sistent asthma in 2001 or 2002. RESULTS: Higher copayments
for asthma prescription drugs did not affect the use of asthma
prescription drugs for children with asthma (any use, number of
prescriptions or number of prescriptions conditional on use (p >
0.10)). Conversely, adults with asthma were price-sensitive to
copayments for asthma drugs on all measures of use (p < 0.01).
These ﬁndings also held for children and adults who were diag-
nosed with asthma in both years. In addition, parents who 
children with asthma had tended to be less price-sensitive than
other adults. CONCLUSION: Commercially-insured parents 
in employer-sponsored health plans may be less sensitive to 
prescription drug prices, and may err on the side of caution by
providing medications to their children with asthma.
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OBJECTIVES: To examine how patients, by use of a discrete
choice experiment, decide between visiting their general practi-
tioner or community pharmacist for the management of minor
ailments. METHODS: Focus groups were convened to identify
key attributes of interest and to explore feasible variation in these
attributes (levels). A postal DCE questionnaire was administered
to adult populations across Wales, UK. The attributes (levels)
chosen were: Location of consultation (GP surgery/pharmacy);
When seen (immediately/not immediately); Travel time (15
minutes/30 minutes); Length of consultation (5 minutes/10
minutes); Expenses (£2/£4). Each questionnaire included 17 
pairwise choices and 109 respondents generated 2006 usable
answers. A two-level logistic regression was performed to
analyse the data. RESULTS: Signiﬁcant beta coefﬁcients were
evident for all attributes other than location of consultation. The
largest increase in utility was with being seen immediately as
opposed to not immediately (Beta = 2.176; SE 0.174; p < 0.001).
A 10 minute consultation was preferred to a 5 minute consulta-
tion with GPs, however respondents preferred a quick consulta-
tion if they visited their community pharmacies. Being able to
save £2 and going to their GPs gave an increase in utility, regard-
less of whether they were seen by their GPs or pharmacists.
CONCLUSION: Everything else being equal, respondents pre-
ferred to see their GPs as their ﬁrst port of call, and to be seen
quickly with little travel time. There is potential to improve the
efﬁciency of policies aiming to increase the use of community
pharmacies in the management of minor ailments. This may be
accomplished by reinforcing the beneﬁts of the immediate and
local availability of community pharmacies that can offer brief
consultations, often at less or the same cost as consulting a
general practitioner to receive a prescription medicine.
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OBJECTIVES: Although the relationship between physician
waiting times and patient satisfaction has been examined, 
the inﬂuence of subsequent time spent with the physician on 
this relationship yet remains to be explored. This study examined
the relationship between patient waiting times, time spent with
the physician, and patient satisfaction ratings with primary care
physicians. METHODS: Cross-sectional survey data on a sample
of 5030 patients who rated their physicians on a web-based survey
developed to collect detailed information on patient experiences
with health care. The survey included self-reported information
on wait times, time spent with physician, and patient satisfaction.
RESULTS: Longer waiting times were associated with signiﬁ-
cantly lower patient satisfaction (p < 0.05); however, time spent
with the physician was the strongest correlate of satisfaction with
physician (partial rho = 0.51, p < 0.001). The decrement in sat-
isfaction associated with long waiting times is substantially
reduced with increased time spent with the physician (5 minutes
or more). Importantly, the combination of long waiting time to
see the physician and having a short physician visit is associated
with very low overall patient satisfaction. CONCLUSION: The
time spent with the physician is a stronger predictor of patient
satisfaction than the time spent in the waiting room. These results
suggest that shortening patient waiting times at the expense of
time spent with the patient to improve patient satisfaction scores
would be counter-productive.
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OBJECTIVES: Pharmaceutical samples are widely used for pro-
motion and marketing, yet little is known about who receives
samples or how their use is associated with patient’s out-of-pocket
prescription costs. We sought to examine the characteristics of
patients receiving samples and to describe the association between
sample receipt and prescription costs METHODS: We divided
the 2002–2003 Medical Expenditure Panel Survey, a nationally
representative, panel-design longitudinal study, into a baseline
period (the ﬁrst two interview rounds) and an analysis period (the
remaining three rounds). We conducted logistic and generalized
linear regression analysis of 5,881 individuals receiving no sample
during the baseline period. We deﬁned our main outcome mea-
sures as: (1) sample receipt, (2) out-of-pocket prescription expen-
ditures, and (3) total prescription expenditures. RESULTS: A total
of 781 (14%) individuals received at least one pharmaceutical
sample during the analysis period. On multivariate analyses
sample receipt was greater among those who were younger and
those not on Medicaid. In generalized linear regressions control-
ling for demographic characteristics and health care utilization,
the 180-day out-of-pocket prescription expenditures were $178
(standard error [SE] $3.9) for those never receiving samples.
Among those receiving samples, the corresponding out-of-pocket
prescription expenditures were $166 (SE $8.9) for periods before
sample receipt, $244 (SE $9.2) for periods during sample receipt,
and $212 (SE $12.4) for periods following sample receipt. Results
were similar when total prescription costs were examined. Analy-
ses stratiﬁed by baseline health care utilization and by sample use
for acute vs. chronic conditions suggested that “pent-up demand”
failed to explain the associations observed. CONCLUSION: Indi-
viduals receiving samples have higher prescription expenditures
than their counterparts. This ﬁnding suggests that sample recip-
ients remain disproportionately burdened by prescription costs
even after sample receipt.
